Literature DB >> 9683067

Behaviour of spermatogonia following recovery from busulfan treatment in the rat.

F X Jiang1.   

Abstract

This study describes the morphological behaviour of spermatogonia following recovery from two doses of busulfan treatment in the rat. Twenty days after the second intraperitoneal injection of busulfan, the testes lost most of their spermatogenic cells and there were fewer dispersed singly surviving spermatogonia. These surviving cells were in close contact with the basal portions of adjacent Sertoli cells and the shrunken basal lamina, and were the source for repopulating the depleted seminiferous epithelium. During the initial stage of repopulation (48 days later), surviving spermatogonia underwent a phase of active proliferation: type A spermatogonia underwent symmetric and asymmetric divisions; type B spermatogonia underwent asynchronous differentiation. At day 96, normal spermatogenesis was fully recovered in many seminiferous tubules, represented by 80% of the rats regaining various degrees of fertility at day 120. These data provide an additional model for the study of self-renewal of stem spermatogonia and suggest that the asymmetric division of type A spermatogonia and their close contact with both the basal lamina and the Sertoli cells may be involved in regulating the number of stem spermatogonia and the delicate process of normal spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683067     DOI: 10.1007/s004290050164

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  9 in total

1.  Sox3 functions in a cell-autonomous manner to regulate spermatogonial differentiation in mice.

Authors:  Monica M Laronda; J Larry Jameson
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

2.  Suppression of spermatogenesis for cell transplantation in adult mice.

Authors:  P Vecino; J A Uranga; J Aréchaga
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

3.  Seminiferous epithelium damage after short period of busulphan treatment in adult rats and vitamin B12 efficacy in the recovery of spermatogonial germ cells.

Authors:  Sandi Regina Vasiliausha; Flávia Luciana Beltrame; Fabiane de Santi; Paulo Sérgio Cerri; Breno Henrique Caneguim; Estela Sasso-Cerri
Journal:  Int J Exp Pathol       Date:  2016-08-31       Impact factor: 1.925

4.  Optimal dose of busulfan for depleting testicular germ cells of recipient mice before spermatogonial transplantation.

Authors:  De-Zhi Wang; Xin-Hua Zhou; Yu-Lin Yuan; Xin-Min Zheng
Journal:  Asian J Androl       Date:  2009-12-14       Impact factor: 3.285

5.  Effect of protopanaxatriol saponin on spermatogenic stem cell survival in busulfan-treated male mice.

Authors:  Minyoung Ji; Naojiro Minami; Masayasu Yamada; Hiroshi Imai
Journal:  Reprod Med Biol       Date:  2007-05-14

6.  Full field optical coherence tomography can identify spermatogenesis in a rodent sertoli-cell only model.

Authors:  Ranjith Ramasamy; Joshua Sterling; Maryem Manzoor; Bekheit Salamoon; Manu Jain; Erik Fisher; Phillip S Li; Peter N Schlegel; Sushmita Mukherjee
Journal:  J Pathol Inform       Date:  2012-02-29

7.  The Effect of a Unilateral Orchiectomy before Gonadotoxic Treatment on the Contralateral Testis in Adult and Prepubertal Rats.

Authors:  Charlotte Rombaut; Katrien Faes; Ellen Goossens
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

8.  Gene and histomorphology alteration analysis in spermatogenesis arrest mouse model: a probable novel approach for infertility.

Authors:  Amirreza Nabighadim; Fahimeh Jafarnezhad-Ansariha; Masoumeh Majidi Zolbin; Seyedeh Sima Daryabari; Kiarad Fendereski; Abdol Mohammad Kajbafzadeh
Journal:  Cent European J Urol       Date:  2020-12-31

9.  Busulfan induced azoospermia: Stereological evaluation of testes in rat.

Authors:  Mohadeseh Panahi; Saeideh Keshavarz; Farhad Rahmanifar; Amin Tamadon; Davood Mehrabani; Negar Karimaghai; Masood Sepehrimanesh; Heydar Aqababa
Journal:  Vet Res Forum       Date:  2015-12-15       Impact factor: 1.054

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.